Loading patent…
AssigneeShihuida Pharmaceutical Group (Jilin) Co., Ltd.
InventorsYong Wang, Yuanyuan Liu, Wenhua Zhang, Yanqiu Xing, Shaopeng Wang, Dan Wang, Hong Zhu, Xinglu Xu, Shengbiao Jiang, Xiaonan Li, Jiahui Zheng, Rong Zhang, Dongxia Yang, Yuxia Gao, Shili Shao, Ting Han
Estimating the term…
The present disclosure provides use of Clostridium ghonii combined with a tumor angiogenesis inhibitor in preparing a pharmaceutical product for treating a tumor. The present disclosure further provides a drug for treating a tumor, where the drug includes active ingredients of Clostridium ghonii and a tumor angiogenesis inhibitor.
A pharmaceutical product for treating a tumor, comprising a Clostridium ghonii combined with apatinib, wherein every 1×107 Colony Forming Units (CFU) of the Clostridium ghonii in a spore form is combined with the apatinib at a dose of 60 mg/kg/d.
A method for treating a tumor, wherein Clostridium ghonii is administered in combination with apatinib;
Dependencies are inferred from the claim text.